Dr. Reddy’s Laboratories Announces Launch of Oral Semaglutide Biosimilar ‘Obeda®’ (tablets) in India
HYDERABAD, INDIA | 20th MAY 2026 | Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred...
